How long did you take this medication to work?
What is Ciprofloxacin-Uropharm?
Ciprofloxacin-Uropharm ear suspension is used to treat bilateral otitis media with effusion (middle ear infection with thick or sticky fluid behind the eardrum) in children undergoing surgical placement of tubes in the ears. Ciprofloxacin-Uropharm belongs to the class of medicines known as fluoroquinolone antibiotics. It works by killing the bacteria or preventing their growth.
Ciprofloxacin-Uropharm is to be given by or under the direct supervision of your doctor.
Ciprofloxacin-Uropharm XR is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the conditions and patient populations listed below.
Uncomplicated Urinary Tract Infections (Acute Cystitis)
Ciprofloxacin-Uropharm XR is indicated for the treatment of uncomplicated urinary tract infections (UTIs) caused by Escherichia coli, Proteus mirabilis, Enterococcus faecalis, or Staphylococcus saprophyticus.
Complicated Urinary Tract Infections, and Acute Uncomplicated Pyelonephritis
Ciprofloxacin-Uropharm XR is indicated for the treatment of complicated urinary tract infections (cUTI) caused by Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, Proteus mirabilis, or Pseudomonas aeruginosa and acute uncomplicated pyelonephritis (AUP) caused by Escherichia coli.
Limitations of Use
- The safety and efficacy of Ciprofloxacin-Uropharm XR in treating infections other than urinary tract infections has not been demonstrated.
- Ciprofloxacin-Uropharm XR is not indicated for pediatric patients.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ciprofloxacin-Uropharm XR and other antibacterial drugs, CiproXR should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.
When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to Ciprofloxacin-Uropharm. Therapy with Ciprofloxacin-Uropharm XR may be initiated before results of these tests are known; once results become available appropriate therapy should be continued. Culture and susceptibility testing performed periodically during therapy will provide information not only on the therapeutic effect of the antimicrobial agent but also on the possible emergence of bacterial resistance.
How should I use Ciprofloxacin-Uropharm?
Use Cetraxal exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.
Do not take by mouth. Cetraxal is for use only in the ears.
Ciprofloxacin-Uropharm should be used 2 times daily for 7 days, unless your doctor tells you otherwise. Your doses should be spaced at least 12 hours apart.
Wash your hands before using the ear drops.
To use the Ciprofloxacin-Uropharm:
Warm the container by holding it in your hands for at least 1 minute. Using Ciprofloxacin-Uropharm that are cold may cause dizziness when you place the medicine into your ear.
Lie down or tilt your head with your ear facing upward. Open the ear canal by gently pulling your ear back, or pulling downward on the earlobe when giving Cetraxal to a child.
Hold the dropper upside down over your ear. Squeeze the bottle until all of the medicine drops into the ear.
Stay lying down or with your ear facing upward for at least 1 minute to allow the medicine to reach the back of your ear canal.
If you are treating both ears, repeat these steps using a second bottle of ear drops.
Each bottle of Ciprofloxacin-Uropharm contains enough medicine for only one ear. If you are treating both ears, use a separate bottle for each ear. You will receive a supply of 14 bottles for the full 7-day treatment of both ears. Throw away a container after one use, even if there is still some medicine left in it.
Use Cetraxal for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics.
Store the medicine at room temperature away from moisture, heat, and light. Keep each Cetraxal single-use ear drop container in the foil pouch until you are ready to give a dose.
For the first few days after ear tube surgery, your child may have some drainage from the ear(s). Call your doctor if the child has a fever, ear pain, or drainage that lasts longer than a few days.
Uses of Ciprofloxacin-Uropharm in details
Ciprofloxacin-Uropharm is used to treat wide range of bacterial infections including lung or respiratory tract infections, eye infection, bladder and kidney infections, reproductive tract infections, skin and soft tissue infections and bone and joint infections.
Ciprofloxacin-Uropharm is a drug used to treat bacterial infections. It is a second generation fluoroquinolone antibacterial. It kills bacteria by interfering with the enzymes that cause DNA to rewind after being copied, which stops DNA and protein synthesis.
Ciprofloxacin-Uropharm is marketed worldwide with over three hundred different brand names. In the United States, Canada and the UK, it is marketed as Ciloxan, Ciprofloxacin-Uropharm, Ciprofloxacin-Uropharm XR, Ciprofloxacin-Uropharm XL Ciproxin and, most recently, Proquin. In Mexico it is available over the counter and marketed under the names Ciproflox or Ciprofloxacino. In Ecuador it is available and marketed under the name Cidrax. In Nigeria it is sold as Ciprotab while in Bangladesh it is marketed as Tablets and Microcapsules for Suspension by numerous companies, one of which is by Edruc Limited as Cipron. Additionally, Ciprofloxacin-Uropharm is available as a generic drug under a variety of different brand names and is also available for limited use in veterinary medicine.
Ciprofloxacin-Uropharm was first patented in 1983 by Bayer A.G. and subsequently approved by the United States Food and Drug Administration (FDA) in 1987.Ciprofloxacin-Uropharm has 12 F.D.A.-approved human uses and other veterinary uses, but it is often used for non-approved uses (off-label).
Ciprofloxacin-Uropharm interacts with other drugs, herbal and natural supplements, and thyroid medications.
Active ingredient matches for Ciprofloxacin-Uropharm:
Ciprofloxacin in Germany.
- DailyMed. "CIPROFLOXACIN; DEXAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailymed/se... (accessed September 18, 2017).
- Wikipedia. "ciprofloxacin: Link to the compound information in Wikipedia.". https://en.wikipedia.org/wiki/Ciprofloxa... (accessed September 18, 2017).
- PubChem. "ciprofloxacin". https://pubchem.ncbi.nlm.nih.gov/compoun... (accessed September 18, 2017).
- FDA Orange Book. "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE: The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).". https://www.fda.gov/Drugs/InformationOnD... (accessed September 18, 2017).
ReviewsThe results of a survey conducted on ndrugs.com for Ciprofloxacin-Uropharm are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Ciprofloxacin-Uropharm. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported usefulNo survey data has been collected yet
Consumer reported price estimatesNo survey data has been collected yet
Consumer reported time for resultsNo survey data has been collected yet
Consumer reported ageNo survey data has been collected yet